A critical review of the impact of candidate copy number variants on autism spectrum disorder

Seyedeh Sedigheh Abedini, Shiva Akhavantabasi, Yuheng Liang, Julian Ik‐Tsen Heng, Roohallah Alizadehsani, Abdollah Dehzangi, Denis C. Bauer, Hamid Alinejad‐RoknyMutation 2024 · DOI

TL;DR

This review critically examines the role of Copy Number Variations (CNVs) in Autism Spectrum Disorder (ASD), identifying 47 specific CNV regions associated with ASD. By analyzing genes within these regions, the study highlights the significant involvement of both protein-coding genes and long non-coding RNAs (lncRNAs) in ASD's genetic underpinnings, offering a valuable resource for future research and diagnostics.

What Problem Does This Paper Address?

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder with a significant genetic component. While genetic factors are known to play a crucial role, pinpointing specific genetic variations and their mechanisms remains a challenge. Copy Number Variations (CNVs), which are deletions or duplications of DNA segments, are known to be present in a substantial portion of individuals with ASD (10-20%). However, a comprehensive understanding of which specific CNV regions and the genes within them are most strongly associated with ASD, and how these variations impact neurodevelopment, is still evolving. This paper aims to address this gap by systematically reviewing and analyzing identified ASD-associated CNV regions and their candidate genes, with a particular focus on the potential role of long non-coding RNAs (lncRNAs).

Methods

The authors employed an integrative bioinformatics approach. They utilized a previously developed tool, SNATCNV, to identify significant CNV regions from a large dataset of ASD cases and controls. This was complemented by PeakCNV. They then performed a comprehensive literature search to gather information on known ASD-associated genes and their functions. For the identified CNV regions, they analyzed gene expression data from the FANTOM5 atlas to identify brain-enriched genes and examined the Mouse Genome Informatics (MGI) resource for genes with nervous system phenotypes in mutant mice. Additionally, they investigated the expression of non-coding RNAs during induced pluripotent stem cell (iPSC) to neuron differentiation.

Datasets

The study utilized the SFARI CNV dataset, which contains data from 19,663 autistic samples and 6,479 healthy control samples. This dataset was converted to the UCSC hg19 genome build. Gene expression data was sourced from the FANTOM5 atlas. Information on mouse nervous system phenotypes was obtained from the Mouse Genome Informatics (MGI) resource.

Key Insights and Ideas

  • CNVs are a major player: The study reinforces that CNVs are not just a minor contributor but a significant factor in ASD etiology, with a substantial number of identified regions showing strong statistical association.
  • Beyond protein-coding genes: A key insight is the highlighted role of long non-coding RNAs (lncRNAs) in ASD. The analysis identified numerous lncRNAs within ASD-associated CNV regions that are highly expressed in the brain and show dynamic expression during neuronal differentiation, suggesting their critical involvement in neurodevelopment.
  • Brain-specific expression is crucial: Genes with enriched expression in the brain were prioritized, underscoring the direct link between genetic variations in these regions and neurodevelopmental processes relevant to ASD.
  • A resource for future research: The identification of 47 specific CNV regions and the associated candidate genes (both coding and non-coding) provides a valuable curated list for further investigation, diagnostic development, and therapeutic target identification.
  • Complexity of genotype-phenotype correlation: The review implicitly points to the challenge of directly linking specific CNVs to ASD phenotypes due to incomplete penetrance and variable expressivity, necessitating a broad approach to candidate gene identification.

Key Results

The study identified 47 CNV regions significantly associated with ASD. Within these regions, they found 1,632 genes, including 856 protein-coding genes and 776 non-coding RNAs. Of these, 552 genes showed significant expression in the brain. They identified 17 regions containing known ASD-associated protein-coding genes. For the remaining regions, they identified 24 regions with protein-coding genes exhibiting brain-enriched expression and nervous system phenotypes in mouse models, and one lncRNA with similar brain-enriched expression and upregulation during neuronal differentiation.

Limitations and Future Work

The authors acknowledge that while their study identifies candidate genes, further experimental validation is needed to confirm their direct role in ASD pathogenesis. The complexity of genotype-phenotype correlations remains a challenge, and the precise mechanisms by which these CNVs and associated genes contribute to ASD are not fully elucidated. Future work should focus on:

  • Functional validation: Investigating the functional impact of identified candidate genes, particularly lncRNAs, using experimental models.
  • Mechanism elucidation: Delving deeper into how these CNVs and genes disrupt neurodevelopmental pathways.
  • Therapeutic targets: Exploring the potential of these identified genes as targets for novel therapeutic interventions.
  • Diagnostic tools: Utilizing the identified CNV regions and genes to improve diagnostic accuracy for ASD.
  • Chromatin interaction analysis: Further exploring the regulatory roles of lncRNAs through tools like MaxHiC and MHiC.

Summary updated

Abstract

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder (NDD) influenced by genetic, epigenetic, and environmental factors. Recent advancements in genomic analysis have shed light on numerous genes associated with ASD, highlighting the significant role of both common and rare genetic mutations, as well as copy number variations (CNVs), single nucleotide polymorphisms (SNPs) and unique de novo variants. These genetic variations disrupt neurodevelopmental pathways, contributing to the disorder's complexity. Notably, CNVs are present in 10 %-20 % of individuals with autism, with 3 %-7 % detectable through cytogenetic methods. While the role of submicroscopic CNVs in ASD has been recently studied, their association with genomic loci and genes has not been thoroughly explored. In this review, we focus on 47 CNV regions linked to ASD, encompassing 1632 genes, including protein-coding genes and long non-coding RNAs (lncRNAs), of which 659 show significant brain expression. Using a list of ASD-associated genes from SFARI, we detect 17 regions harboring at least one known ASD-related protein-coding gene. Of the remaining 30 regions, we identify 24 regions containing at least one protein-coding gene with brain-enriched expression and a nervous system phenotype in mouse mutants, and one lncRNA with both brain-enriched expression and upregulation in iPSC to neuron differentiation. This review not only expands our understanding of the genetic diversity associated with ASD but also underscores the potential of lncRNAs in contributing to its etiology. Additionally, the discovered CNVs will be a valuable resource for future diagnostic, therapeutic, and research endeavors aimed at prioritizing genetic variations in ASD.
BibTeX
@inproceedings{abedini2024critical,
  author = {Seyedeh Sedigheh Abedini and Shiva Akhavantabasi and Yuheng Liang and Julian Ik‐Tsen Heng and Roohallah Alizadehsani and Abdollah Dehzangi and Denis C. Bauer and Hamid Alinejad‐Rokny},
  title = {{A critical review of the impact of candidate copy number variants on autism spectrum disorder}},
  booktitle = {Mutation},
  year = {2024},
  doi = {10.1016/j.mrrev.2024.108509},
}
Figure